This federal contract award is for the delivery of FLUTICASONE-SALMETEROL 115-21 12GM pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,423.32 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 29, 2024 with an ultimate completion date of October 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of the pharmaceutical product "FLUTICASONE-SALMETEROL 230-21 12GM" to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $3,887.90. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of December 16, 2024. There is no set-aside...
This federal contract award is for the delivery of FLUTICASONE-SALMETEROL 230-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $6,092.89, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is November 7, 2024. The contract is not associated with a set-aside...
This federal contract award is for the delivery of Fluticasone-Salmeterol 230-21 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $8,346.72, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 17, 2024. The contract was not designated with a set-aside...
This federal contract award is for the delivery of fluticasone-salmeterol 45-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,035.88 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 24, 2025, with a completion date of January 27, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of FLUTICASONE-SALMETEROL 45-21 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The $5,786.50 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, on April 22, 2024. The contract has an ultimate completion date of April 23, 2024 and is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to...
This federal contract award is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,237.14 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 19, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order valued at $1,005.72 with a firm fixed price, which provides for the delivery of FLUTICASONE-SALMETEROL 45-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025 and was awarded on January 7, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, valued at $1,213.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, and has an ultimate completion date of January 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen holds a...
This federal contract award is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,981.33 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024, with a completion date of December 10, 2024. The contract is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp maintains a $999,999,999 Indefinite...